Literature DB >> 9773449

DEXA: a practical and accurate tool to demonstrate total and regional bone loss, lean tissue loss and fat mass gain in paraplegia.

L M Jones1, A Goulding, D F Gerrard.   

Abstract

Persons with spinal cord injury lose lean tissue mass and bone but gain body fat. There is a need to quantify the magnitude of these changes in body composition because there are associated skeletal and cardiovascular health risks. We have compared total body and regional (lower limb) differences in body composition in a group of males with paraplegia and in healthy able-bodied males matched for age, and height using dual energy X-ray absorptiometry. Although patients and controls had similar body mass indices, significant reductions in lean tissue mass (16% less) and bone (12% less) were observed in those with spinal cord injury. Group differences were even more pronounced in the lower limb. DEXA also revealed large increases in fat mass in subjects who did not look obese, total fat mass being 47% higher in the paraplegic group. We suggest that DEXA provides a simple and practical means to quantify both whole body and regional changes in body composition associated with spinal cord injury.

Entities:  

Mesh:

Year:  1998        PMID: 9773449     DOI: 10.1038/sj.sc.3100664

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  23 in total

Review 1.  Bone loss and muscle atrophy in spinal cord injury: epidemiology, fracture prediction, and rehabilitation strategies.

Authors:  Lora Giangregorio; Neil McCartney
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

2.  Identification and Management of Cardiometabolic Risk after Spinal Cord Injury.

Authors:  Mark S Nash; Suzanne L Groah; David R Gater; Trevor A Dyson-Hudson; Jesse A Lieberman; Jonathan Myers; Sunil Sabharwal; Allen J Taylor
Journal:  J Spinal Cord Med       Date:  2019-06-10       Impact factor: 1.985

3.  Validity of one-repetition maximum predictive equations in men with spinal cord injury.

Authors:  F Ribeiro Neto; P Guanais; E Dornelas; A C B Coutinho; R R G Costa
Journal:  Spinal Cord       Date:  2017-05-09       Impact factor: 2.772

4.  Identification and Management of Cardiometabolic Risk after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers.

Authors:  Mark S Nash; Suzanne L Groah; David R Gater; Trevor A Dyson-Hudson; Jesse A Lieberman; Jonathan Myers; Sunil Sabharwal; Allen J Taylor
Journal:  Top Spinal Cord Inj Rehabil       Date:  2018

5.  Weight gain following spinal cord injury: a pilot study.

Authors:  Deborah A Crane; James W Little; Stephen P Burns
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

Review 6.  Effects of spinal cord injury on body composition and metabolic profile - part I.

Authors:  Ashraf S Gorgey; David R Dolbow; James D Dolbow; Refka K Khalil; Camilo Castillo; David R Gater
Journal:  J Spinal Cord Med       Date:  2014-07-07       Impact factor: 1.985

7.  Relationship Between Gonadal Function and Cardiometabolic Risk in Young Men With Chronic Spinal Cord Injury.

Authors:  Shannon D Sullivan; Mark S Nash; Eshetu Tefara; Emily Tinsley; Suzanne Groah
Journal:  PM R       Date:  2017-08-18       Impact factor: 2.298

8.  Physical exercise is associated with better fat mass distribution and lower insulin resistance in spinal cord injured individuals.

Authors:  Giselle Louise C D'Oliveira; Flávia A Figueiredo; Magna Cottini Fonseca Passos; Amina Chain; Flávia F Bezerra; Josely Correa Koury
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

9.  Femoral loads during passive, active, and active-resistive stance after spinal cord injury: a mathematical model.

Authors:  Laura A Frey Law; Richard K Shields
Journal:  Clin Biomech (Bristol, Avon)       Date:  2004-03       Impact factor: 2.063

Review 10.  Exercise recommendations for individuals with spinal cord injury.

Authors:  Patrick L Jacobs; Mark S Nash
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.